Pace Life Sciences LLC, a U.S.-based contract research, development, and manufacturing organization (CRDMO), is remodeling and expanding its Salem, New Hampshire, site to establish a Center of Excellence for Aseptic Fill-Finish Processing.

The expansion of the Salem, NH, facility includes the addition of an isolated vial filling line designed to facilitate smaller batch size manufacturing with high sterility assurance and EU Annex 1 compliance. This fill line, along with other facility enhancements, allows Pace to serve clients requiring cGMP manufacturing in the injectable space for vaccines, gene therapies, antibodies, and protein-based therapeutics.

Dawn Von Rohr, President of Pace Life Sciences, said, “The remodel of our state-of-the-art facility in Salem, NH, ensures that we can scale alongside our clients as their programs evolve and regulatory expectations advance. We look forward to welcoming visitors to showcase our advanced capabilities and enhancements.”